| 11820825 |
Methods of treating a subject having an EGFR-positive and/or ErbB-3-positive tumor |
Ton Logtenberg, Robertus Cornelis ROOVERS |
2023-11-21 |
| 11785924 |
Antibody producing non-human animals |
Ton Logtenberg, Robert A. Kramer, Rui Daniel Pinto, Cornelis Adriaan De Kruif, Erwin Houtzager |
2023-10-17 |
| 11780925 |
ErbB-2 and ErbB3 binding bispecific antibodies for use in the treatment of cells that have an NRG1 fusion gene |
Cecilia Anna Wilhelmina GEUIJEN, David Andre Baptiste Maussang-Detaille, Ton Logtenberg |
2023-10-10 |
| 11773170 |
Antibodies that bind EGFR and cMET |
Cecilia Anna Wilhelmina GEUIJEN, Robertus Cornelis ROOVERS, Cornelis Adriaan De Kruif, Ton Logtenberg |
2023-10-03 |
| 11753470 |
Bispecific anti PD1-anti TIM3 antibodies |
Cecilia Anna Wilhelmina GEUIJEN, Rinse KLOOSTER, Cornelis Adriaan De Kruif, Paulus Johannes TACKEN, Ton Logtenberg |
2023-09-12 |
| 11732043 |
Antibodies that modulate a biological activity expressed by a cell |
Cecilia Anna Wilhelmina GEUIJEN, Rinse KLOOSTER, Cornelis Adriaan De Kruif, Paulus Johannes TACKEN, Ton Logtenberg |
2023-08-22 |
| 11685786 |
Binding molecules that bind CD137 and PD-L1 |
Cecilia Anna Wilhelmina GEUIJEN, Cornelis Adriaan De Kruif, Rinse KLOOSTER, Paulus Johannes TACKEN, Ton Logtenberg |
2023-06-27 |
| 11667714 |
Binding molecules that modulate a biological activity expressed by a cell |
Cecilia Anna Wilhelmina GEUIJEN, Rinse KLOOSTER, Cornelis Adriaan De Kruif, Paulus Johannes TACKEN, Ton Logtenberg |
2023-06-06 |
| 11559049 |
Antibody producing non-human animals |
Ton Logtenberg, Robert A. Kramer, Rui Daniel Pinto, Cornelis Adriaan De Kruif, Erwin Houtzager |
2023-01-24 |